THE PROGNOSTIC-SIGNIFICANCE OF URINARY BETA-CORE FRAGMENT IN PREMENOPAUSAL WOMEN WITH CARCINOMA OF THE CERVIX

被引:29
作者
CARTER, PG
ILES, RK
NEVEN, P
IND, TEJ
SHEPHERD, JH
CHARD, T
机构
[1] Williamson Laboratory for Molecular Oncology, Joint Academic Unit of Obstetrics, Gynaecology, and Reproductive Physiology, The Medical College of St. Bartholomew's Hospital, University of London, London EC1A 7BE, West Smithfield
关键词
D O I
10.1006/gyno.1994.1289
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The mortality of premenopausal women with cervical carcinoma has increased in recent decades despite attempts to provide screening. The urinary concentration of the beta core fragment of hCG has been proposed as a sensitive marker in gynecological malignancies, although most studies have not corrected for urine concentration, We measured the urinary concentration of beta core and creatinine in 61 women who developed cervical cancer premenopausally and expressed the concentration of beta core per millimole of creatinine using the 90th percentile of a control group as a cutoff level. While correcting for urinary concentration results in a reduction in sensitivity of the test (67 to 51%), there is improved correlation with prognosis in that after 18 months 81% of women positive for beta core had died, while 80% of women negative for beta core were still alive. Of those initially presenting and dying there was an increase with increasing stage of disease. For patients with initial presentation disease, 11 (79%) of the 14 patients with elevated levels had died compared with 1 of 21 (5%) who were negative for beta core. Urinary beta core fragment may have a major role as a prognostic indicator in cervical carcinoma rather than as a screening or diagnostic marker and enables identification of patients at higher risk of an aggressive disease. (C) 1994 Academic Press, Inc.
引用
收藏
页码:271 / 276
页数:6
相关论文
共 17 条
[1]   HUMAN CHORIONIC GONADOTROPIN-LIKE AND BETA-CORE-LIKE MATERIALS IN POSTMENOPAUSAL URINE [J].
AKAR, AH ;
GERVASI, G ;
BLACKER, C ;
WEHMANN, RE ;
BLITHE, DL ;
NISULA, BC .
JOURNAL OF ENDOCRINOLOGY, 1990, 125 (03) :477-484
[2]   PURIFICATION OF BETA-CORE FRAGMENT FROM PREGNANCY URINE AND DEMONSTRATION THAT ITS CARBOHYDRATE MOIETIES DIFFER FROM THOSE OF NATIVE HUMAN CHORIONIC GONADOTROPIN-BETA [J].
BLITHE, DL ;
AKAR, AH ;
WEHMANN, RE ;
NISULA, BC .
ENDOCRINOLOGY, 1988, 122 (01) :173-180
[3]   HORMONAL PROFILES AFTER MENOPAUSE [J].
CHAKRAVARTI, S ;
COLLINS, WP ;
FORECAST, JD ;
NEWTON, JR ;
ORAM, DH ;
STUDD, JWW .
BRITISH MEDICAL JOURNAL, 1976, 2 (6039) :784-787
[4]  
COLE LA, 1988, CANCER RES, V48, P1356
[5]   DETECTION OF THE FREE BETA-SUBUNIT OF HUMAN CHORIONIC-GONADOTROPIN (HCG) IN CULTURES OF NORMAL AND MALIGNANT TROPHOBLAST CELLS, PREGNANCY SERA, AND SERA OF PATIENTS WITH CHORIOCARCINOMA [J].
COLE, LA ;
HARTLE, RJ ;
LAFERLA, JJ ;
RUDDON, RW .
ENDOCRINOLOGY, 1983, 113 (03) :1176-1178
[6]  
Franchimont P, 1978, Curr Top Exp Endocrinol, V3, P201
[7]  
HUSSA RO, 1987, CLIN MARKER HCG, P128
[8]   IMMUNOREACTIVE BETA-CORE-LIKE MATERIAL IN NORMAL POSTMENOPAUSAL URINE - HUMAN CHORIONIC-GONADOTROPIN OR LH ORIGIN - EVIDENCE FOR THE EXISTENCE OF LH CORE [J].
ILES, RK ;
LEE, CL ;
HOWES, I ;
DAVIES, S ;
EDWARDS, R ;
CHARD, T .
JOURNAL OF ENDOCRINOLOGY, 1992, 133 (03) :459-466
[9]   THE PURIFICATION AND DEVELOPMENT OF A RADIOIMMUNOASSAY FOR BETA-CORE FRAGMENT OF HUMAN CHORIONIC-GONADOTROPIN IN URINE - APPLICATION AS A MARKER OF GYNECOLOGICAL CANCER IN PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN [J].
LEE, CL ;
ILES, RK ;
SHEPHERD, JH ;
HUDSON, CN ;
CHARD, T .
JOURNAL OF ENDOCRINOLOGY, 1991, 130 (03) :481-489
[10]   URINARY GONADOTROPIN FRAGMENT, A NEW TUMOR-MARKER .1. ASSAY DEVELOPMENT AND CANCER SPECIFICITY [J].
NAM, JH ;
COLE, LA ;
CHAMBERS, JT ;
SCHWARTZ, PE .
GYNECOLOGIC ONCOLOGY, 1990, 36 (03) :383-390